Monthly Archives: November 2016

Post navigation

At the crossroad of medical, psychological, philosophical and moral reflection, this involves complex and fundamental

questioning on respect for life and for the person [1,2]. How can a happy medium be found between abandon and excessive therapeutic intervention? [3,4] How can a decision be reached which respects the person and which may require us to administer additional treatment, or to continue or withdraw treatment already in place? [5] When confronted with a compulsory choice, all doctors, care teams and families then Inhibitors,research,lifescience,medical face the double difficulty of responsibility and doubt. Concerning the determinants of decision-making, besides applying the main ethical principles [6], several Inhibitors,research,lifescience,medical publications [1,2,4,5,7-10] focus on taking directives into account, the role of the person of trust, the need to coordinate teamwork and the participation of carers in the decision-making process, and some others show the need to take into account the religious and moral beliefs of people as well as the cost of care and treatments [11,12]. Benett & al. recently Inhibitors,research,lifescience,medical highlighted the lack of emphasis on research which informs clinical decisions in end of life care [13]. In a recent review of the

different methods used by researchers in the end of life domain [14], the predominant Inhibitors,research,lifescience,medical use of qualitative or mixed methods which called on social science tools

was highlighted (interview, focus group, Arts/drama, Quality of life tools/surveys, Storytelling, Narratives/diaries, Mixed methods). The role of caregivers (healthcare professionals and family) Inhibitors,research,lifescience,medical in the decision-making process must be understood before designing a research protocol on this topic. Their role depends on socio-cultural aspects, organisational aspects, professional guidelines and legislation. In France, if a patient is in an advanced or terminal phase of a Rapamycin price severe and incurable disease, or if a patient receives only artificial Linifanib (ABT-869) life sustaining treatment, French law (Code of Public Health, Law No. 2005-370 of 22 April 2005 on patients’ rights and end of life) allows the clinician caring for the patient to limit or stop unnecessary or disproportionate treatment. The decision is purely the responsibility of the clinician in charge of the patient, but it must be made after discussion with the care team and with a medical consultant outside the department. The patient’s physician must seek and take into account any previous directives made by the patient, and obtain the opinion of the family or relatives.

Clearly, other parameters may influence the cell death modalities induced by nanomaterials, such as the dose or the time of exposure. Depending on the concentration, nano-C60 fullerene caused ROS-mediated necrosis (high dose), or ROS-independent autophagy (low dose) in rat and human glioma cell cultures [137]. The type of cell death induced by silver ions (Ag+) and silver nanoparticle coated with polyvinylpyrrolidone

Inhibitors,research,lifescience,medical were also dependent on the dose and the exposure time, with Ag+ being the most toxic in a human monocytic cell line [138]. The silver nanoparticles concentrations required to elicit apoptosis were found to be much lower than the concentrations required for necrosis in human fibrosarcoma, skin, and testicular Dabrafenib supplier embryonal carcinoma cells [139, 140]. In conclusion, although the reports are

often contradictory, the cell death appears roughly cell type, material composition, and concentration dependent. For instance, it has been reported that TiO2 (5–10nm), Inhibitors,research,lifescience,medical SiO2 (30nm), and MWCNTs (with different size: <8nm, 20–30nm, and >50nm, but same length 0.5–2μm) induce cell-specific responses resulting in variable toxicity and subsequent cell Inhibitors,research,lifescience,medical fate in mouse fibroblasts and macrophages as well as telomerase-immortalized human bronchiolar epithelial cells. Precisely, the macrophages were very susceptible to nanomaterial toxicity, while fibroblasts are more resistant at all the treatments, whereas only the exposure of SiO2 and MWCNT (<8nm) induce apoptosis in human bronchiolar epithelial cells. In the Inhibitors,research,lifescience,medical experimental conditions of this study, the investigated nanomaterials did not trigger necrosis [65]. In the same mouse macrophage cell line, it has been demonstrated that MWCNT (10–25nm) and SWCNTs (1.2–1.5nm)

induced necrosis in a concentration-dependent manner [141]. CNTs have been demonstrated to induce both necrosis and apoptosis in human fibroblasts [142]. In contrast, Cui and co-workers found that SWNTs upregulate apoptosis-associated genes in human embryo kidney cells [143], and Zhu and colleagues showed that MWCNTs induce apoptosis Inhibitors,research,lifescience,medical in mouse embryonic stem cells [144], while Pulskamp and collaborators assert that commercial CNTs do not induce necrosis or apoptosis in rat macrophages [145]. Recently, a multilevel ADP ribosylation factor approach, including different toxicity tests and gene-expression determinations, was used to evaluate the toxicity of two lanthanide-based luminescent nanoparticles, complexes with the chelating agent EDTA. The study revealed that these nanomaterials induced necrosis in human lymphoblasts and erythromyeloblastoid leukemia cell lines, while no toxicity was observed in human breast cancer cell line. Moreover, no in vivo effects have been observed. The comparative analysis of the nanomaterials and their separated components showed that the toxicity was mainly due to the presence of EDTA [146].

The current literature suggests that the GAT has superior measurement precision

compared with the other available tonometers.15 The mean IOP measurements obtained by the ORA and TXL were compared with the measurements obtained by the GAT, using the Student t test. All the data are reported as means ± Ruxolitinib manufacturer standard deviation. Linear regression analysis was used to evaluate the associations between IOP (as measured by the GAT, TXL, and ORA) and CCT, CH, and CRF. Subsequently, all the independent variables were entered into multiple regression models to assess their Inhibitors,research,lifescience,medical relationships with IOP, as measured by the different devices. Bland-Altman plots were constructed to assess the agreement between IOP measurements obtained with the GAT, ORA, and TXL; the mean difference and 95% limits of agreement between the Inhibitors,research,lifescience,medical devices were calculated. The differences between the measurements for each parameter were plotted against their means. Results This study was conducted on 36 eyes of 23 patients with aphakic glaucoma using 2.02±0.87 anti-glaucoma medications and 40 eyes of 20 age- and sex-matched normal subjects. The demographic data, CCT, CH,

and CRF for both groups are shown in table 1. The mean IOP values obtained with each tonometer are illustrated in figure 1 for both groups. The mean±standard deviation of the IOP values obtained by the GAT, TXL, and ORA (IOPcc and IOPg) Inhibitors,research,lifescience,medical and the mean difference in IOP measured by the Inhibitors,research,lifescience,medical TXL and ORA compared to the GAT in both groups are displayed in table 2. In group 1, the values obtained by the TXL (P=0.004), IOPcc (P=0.005), and IOPg (P<0.0001) were significantly greater than the GAT values. The mean difference for the TXL, IOPcc, and IOPg were 2.1, 6.6, and 7.2 mm Hg, respectively. In other words, the IOP reading by the TXL was closer to the GAT IOP reading in the patients with aphakic glaucoma, and the ORA overestimated IOP compared to the GAT. In group 2, Inhibitors,research,lifescience,medical the mean difference of the TXL and IOPcc compared with the GAT was non-significant

132 In extrinsic disorders, such as jet lag and shift work, the unnatural temporal demands of modern society impose on a completely normal circadian and sleep-wake physiology to produce such impairments. For some individuals, such as airline flight crew, the jet lag problem may be chronic and severe. Jet lag could produce dysphoria, anergia, apathy, sleep disturbances, increased

irritability, anxiety, and psychosomatic disturbances, ie, symptoms overlapping depressive disorders. The possibility of a connection between jet lag and Inhibitors,research,lifescience,medical psychiatric disorders has been postulated.133 Clinical and pathophysiological indications suggest that jet lag is a Inhibitors,research,lifescience,medical possible trigger in the exacerbation of existing affective disorders and in the appearance of de novo mood disturbances in predisposed persons. Depressive symptoms are more frequent subsequent to flights from east to west,134 supporting the phase-advance hypothesis for depression.135 In the other sense, eastbound flights, which can be see as a kind of sleep deprivation, can precipitate mania.136 Inhibitors,research,lifescience,medical Psychotic symptoms occurring during

long-distance trips (referred to as “travel paranoia”) have been also reported in the literature.137 The most plausible explanation is that longdistance flights, which involve abrupt environmental changes, can represent a severe crisis situation for predisposed individuals. However, circadian rhythm selleck products abnormalities

have not received much attention in studies of psychosis, and conclusions in this field are inconsistent. Individuals engaged Inhibitors,research,lifescience,medical in shift work experience disturbed sleep and excessive sleepiness due to the fact that their behavioral sleep-wake schedules are out of phase and often in direct opposition to their endogenous Inhibitors,research,lifescience,medical circadian rhythms. In a recent large study that aimed to determine the prevalence and consequences of shift work sleep disorder in a sample of rotating and permanent night workers, Drake et al138 showed greater rates of depression and somatic diseases (gastrointestinal ulcers and cardiovascular diseases), elevated work absenteeism, impaired social and domestic aspects of quality of life, and more accidents, mainly related to symptoms of insomnia or daytime sleepiness. These findings are in accordance with previous studies Cell press showing copious behavioral, health, and social morbidity associated with shift work.139-141 In intrinsic disorders, the pathology of the circadian system itself is responsible for the symptoms. DSPS is characterized by sleep onset and wake times, which are delayed in comparison to conventional sleep-wake times. Enforced ”conventional“ wake times may result in chronically insufficient sleep and excessive daytime sleepiness, and can be associated with irritability and poor performance.

2A). Immunoblot analyses using the obtained antibody detected a major band of 68 kD and

a smear from 68 to 95 kD in cDNA-transfected COS-7 cells, but not in mock-transfected and non-transfected COS-7 cells (Fig. 2B). The 68 kD band agrees well with the predicted molecular mass of rat Gpnmb, and the smear is most likely a glycosylated form. Furthermore, the antibodies recognized two main bands of 68 and 150 kD in a crude membrane fraction prepared from the entire brain (Fig. Inhibitors,research,lifescience,medical 2C). These bands were completely abolished by preadsorption of the antibody with the peptide used for immunization (Fig. 2C). Figure 2 Antibody validation. (A) COS-7 cells that were transfected with an expression plasmid for Gpnmb (Gpnmb) or an empty vector (Mock) and non-transected cells (-) were stained with anti-Gpnmb

antibody and visualized with FITC-conjugated Inhibitors,research,lifescience,medical secondary antibody … Gpnmb-IR in normal rat brain Cerebral cortex Gpnmb-IR was observed in all layers of the cerebral cortex, but staining was most Duvelisib solubility dmso prominent in layers II and III (Fig. 3A). IR was abolished by preadsorption of the primary antibody with the peptide used for immunization (Fig. 3B). Some of the Gpnmb-IR cells appeared to have fine processes (Fig. 3C, D). Double immunofluorescence staining revealed that Gpnmb-IR cells in layers II and III were positive for Inhibitors,research,lifescience,medical the microglia/macrophage markers OX42 (Fig. 4A) and IB4 (Fig. 4B). Although less frequently, some Inhibitors,research,lifescience,medical Gpnmb-IR cells were co-stained for the radial glial lineage marker RC2 (Fig. 4C). In contrast, no co-staining was observed with antibodies

to the astrocyte lineage markers glial fibrillary acidic protein (GFAP; Fig. 4D) and protein S-100β (Fig. 4E) and the neuronal marker NeuN (Fig. 4F). This tendency was the same in other layers, except that occasional co-staining with NeuN was detected in layer VI (Fig. S1). Figure 3 Distribution of Gpnmb-IR in Inhibitors,research,lifescience,medical rat cerebral cortex. (A, B) Layers I–VI of the cortex. Sections obtained from adult rats were stained with anti-Gpnmb antibody before [ A, ads (-)] or after [ B, ads (+)] adsorption with the antigenic peptide and then … Figure 4 Characterization of Gpnmb-IR cells in cortical layers II–III with multiple markers. Sections were double-stained for Gpnmb (FITC, green) and the indicated markers (Texas Red, red). Note that Gpnmb-IR cells are co-stained with OX42, IB4, and RC2 … Hippocampus Gpnmb-IR was observed oxyclozanide throughout the hippocampus (Fig. 5A). IR was abolished by the primary antibody that was preadsorbed with the peptide used for immunization (Fig. 5B). IR in the CA1 segment (Fig. 5C) and dentate gyrus (Fig. 5F) was stronger than that observed in the CA2 and CA3 segments (Fig. 5D, E). With double fluorescence staining, Gpnmb-IR cells co-stained with OX42 or IB4 were observed in the polymorphic cell layer (Fig.

Pillar Three: Diagnose the kind of pain and treat it: for example, neuropathic pain versus nociceptive pain. Pillar Four: Other symptoms, conditions, and complications such as mood and sleep. Pillar Five: Personal responsibility and self management. If you, as the physician, are working harder

than your patient, there is something wrong. The optimal pharmacologic approach to the management of neuropathic pain appears to be a stepwise management algorithm.5 There Inhibitors,research,lifescience,medical are a number of published guidelines, but for the purposes of Canadian urologists, the Canadian guideline is the most appropriate. This describes four levels of neuropathic therapy developed for peripheral neuropathic pain, but in the absence of specific controlled studies may be used as guideposts. There are few Natural Product Library research buy well-controlled pharmacotherapy studies in this area.

Management of chronic pain refractory to conservative treatment, including standard analgesic and condition-specific therapies (see later in Inhibitors,research,lifescience,medical the article), should normally start with a tricyclic and/or gabapentinoid (gabapentin or pregabalin; then go to a drug such as duloxetine Inhibitors,research,lifescience,medical or venlafaxine or a topical medication such as lidocaine, gabapentin, or capsaicin; an opioid such as tramadol, oxycodone, or morphine; and then a variety of agents (Figure 1). Figure 1 Stepwise pharmacologic management of chronic pain refractory to conservative treatment. CR, continuous release; SNRI, serotonin-norepinephrine reuptake inhibitor; TCA, tricyclic antidepressant. [Allan Gordon, MD] CP as a Mechanistic Model of UCPPS The etiology of CP/CPPS is unknown. Our current working hypothesis is that there is likely a trigger event such as infection, trauma, or even stress that, in susceptible individuals, Inhibitors,research,lifescience,medical results Inhibitors,research,lifescience,medical in chronic pelvic pain. The pain is either modulated or perpetuated by factors including psychologic, inflammatory/immune,

neurologic, and endocrine aspects. The clinical manifestation may also be affected by the patient’s social situation. The epidemiology of CP/CPPS suggests that, in some men, it may progress along with other systemic diseases. In the National Institutes of Health (NIH)-sponsored Chronic Prostatitis Cohort study, men with CP/CPPS were six times more likely to report a history of cardiovascular disease than age-matched asymptomatic controls. They were five times more likely to report a history of neurologic disease, and twice as likely from to report sinusitis and anxiety/depression.6 A recent review of the overlap between CP/CPPS, IC/PBS, and systemic pain conditions such as IBS, fibromyalgia, and chronic fatigue syndrome (CFS) found that 21% of men with CPPS report a history of musculoskeletal, rheumatologic, or connective tissue disorder. Men with CP/CPPS report CFS twice as often as asymptomatic controls, and 19% to 79% of men with CPPS report IBS or IBS symptoms.

These accuracy scores were determined by correct answers of locations or object identities based on button presses that indicated responses to text that accompanied the pictures. The cut off for head motion was set as 2 mm. Each participant’s data were examined for continuous motion,

intermittent spikes, and drifts in x, y, and z directions Inhibitors,research,lifescience,medical after the realignment step during data preprocessing. In addition, the Artifact Detection Tools (ART) software was used to identify global mean signal intensity and motion selleck products outliers (Gabrieli Lab, 2009; Whitfield-Gabrieli, Mozes, & Castanon, MIT). Yet, another step was to measure the temporal signal-to-noise ratio of each Inhibitors,research,lifescience,medical participant’s data and a minimum cut off was kept at 40. Thus, the decision to not include a subject’s data in the group analysis was made by taking into consideration all these aspects. Materials The

stimuli were created using grey-scale photographs of a series of small common household objects against a black background. The objects generally fit into the categories of miniature animals, children’s toys, kitchen objects, and clothing items. Each Inhibitors,research,lifescience,medical stimulus presented in the experiment was unique and the presentation of the blocks was pseudorandomized with two tasks (four blocks of object recognition and four blocks of location detection) and a fixation baseline. In the object task, participants recognized a given object and chose the appropriate name for it from a list of four alternatives, and in the location detection task, they detected the location of a given object relative to a cross at the center Inhibitors,research,lifescience,medical of the screen. The objects were positioned in four possible locations (left, right, above, and below) relative to the cross. Participant responses

were recorded using fiber optic buttons. The recorded responses provided the reaction time and performance accuracy data for the object and location tasks. For both tasks, each item was presented for 6 sec during which the participant Inhibitors,research,lifescience,medical chose the correct however answer. Each block consisted of six pictures with an interstimulus interval of 1 sec (see Fig. 1). Figure 1 A pictorial representation of the timing of the trials and the types of stimuli and conditions presented in the study. Data acquisition and analysis All participants practiced the experiment on a laptop computer before the scanning session started. While in the scanner, the software E-Prime 1.2 (Psychology Software Tools, Pittsburgh, PA) was used to present the stimuli. An IFIS (Integrated Functional Imaging System, Invivo Corporation, Orlando, FL) interface projected the data onto a screen behind the participant’s head that was viewed using a mirror. Images were acquired using a 3T Siemens Allegra head-only scanner (Siemens Medical Inc.

2kHz). Figure 6 (A) 2H-spectrum of pure DMPD-d54 in H2O at 298K and in the presence of 4mg CYSP (B), 4mg POLYA (C), and 4mg ASD. The dashed line shows the shifts in the plateau resonance. The situation is quite different when POLYA (R = 1/5) is present in the MLV; here, an = homogenous diminution in quadrupolar splitting is observed for all resonances (e.g., from 4 to 3.6kHz for

the CD3 doublet and from 29 to 26.6kHz for the plateau contribution), indicating overall fluidization of the bilayer at 298K (Figure 6(C)). In addition, the use of a preformed Inhibitors,research,lifescience,medical complex in MLV (R = 1/5), while almost restoring the splitting at the plateau level (28kHz), induced an increase in CD3 splitting (to 4.4kHz), as shown in Figure 6(D). These observations are also visible in the fluidity profile shown in Figure 7. The data used to obtain the top traces were also used to build, for all CD groups, histograms Inhibitors,research,lifescience,medical of relative local fluidity variation by plotting for each resonance in a given system X: R=QSX−QSDMPCQSDMPC, (4) where QSX is the quadrupolar splitting of the system X and Inhibitors,research,lifescience,medical QSDMPC that of the corresponding resonance in the DMPC reference MLV (bottom histograms

of Figure 7). Such a plot, while confirming the previous results, also shows that the most significant rigidification induced by CYSP takes place in the middle of the chain, even if it is also close to

the carbonyl group in the plateau region. Similarly, the fluidizing properties of POLYA Inhibitors,research,lifescience,medical appear to be present at both ends of the chain, while the presence of the complex almost overcomes the effects of CYSP. Temperature dependence: as mentioned in the previous section, the dynamics of DMPD multilayers are characterized by a phase transition from a gel state to a liquid crystal state at a given temperature. This specific transition temperature in DMPD-d54 is also 297K, with a dramatic reduction in quadrupolar splitting (QS) noted around 297K. This transition temperature was not significantly modified Inhibitors,research,lifescience,medical between the Endonuclease different samples used (not shown). However, by increasing the temperature, besides the expected reduction in the QS values (reflecting an increase in fluidity), the fluidity profiles and relative local fluidity modifications appear quite different (e.g., see Figure 7 in the right column at 308K). With regard to DMPD, the CYSP effects appear nearly negligible, while the fluidizing effect of POLYA was more pronounced and homogenous. Furthermore, the presence of the complex results in an overall homogenous rigidification at all chain levels. Figure 7 Pexidartinib mouse 2H-NMR left column: fluidity profile (order parameters) plotted at 298K for DMPC-d54 alone and in the presence of 4mg CYSP (□), 4mg POLYA (), and 4mg ASD (×). The numbering refers … 4.

4 GDC941 patients with acute hyponatremia, developing in the course of ≤12 hours, are more likely to develop symptoms including seizures and coma than those with

chronic hyponatremia (≥3 days).5 Optimal management of hyponatremia is still evolving despite awareness of this electrolyte disturbance since the mid 1900s.4, 5 Most authorities recommend correction of [Na+] in severely hyponatremic and symptomatic patients Inhibitors,research,lifescience,medical by 2 to 4 mEq/L within 2 to 4 hours, <12 mEq/L in 24 hours, and to <18 mEq/L in 48 hours.4, 5 Guidelines for infusion rates of hypertonic saline and monitoring procedures have been introduced, most notably the Adrogué-Madias formula.6 Caution in the use of these formulae has been recommended,7 especially Inhibitors,research,lifescience,medical given that they were designed for use in static conditions. Retrospective studies have found a risk of physicians underestimating the increase in [Na+] after hypertonic saline therapy, particularly

in the setting of extracellular volume depletion.8, 9 A common criticism of these formulae is that they fail to account for ongoing renal and extrarenal fluid and electrolyte losses. Whereas the formulae apply to static conditions, the dynamic nature of the patient’s Inhibitors,research,lifescience,medical hospital course, including intravenous drips and gastrointestinal losses, affects the accuracy of [Na+] replacement by standard calculated deficits. To this effect, more elaborate formulae have been developed7 that better allow the clinician to follow [Na+] levels at close time Inhibitors,research,lifescience,medical intervals to adjust medical management. Treatment guidelines published in 2007 evaluated the situations in which

vasopressin receptor antagonists should be considered as alternatives or supplements to standard therapies.4 Conivaptan is one of these alternative therapies.10, 11 Conivaptan is a nonselective V1AR/V2R vasopressin receptor antagonist available in IV form and approved by the FDA to treat euvolemic hyponatremia in 2005 and hypervolemic hyponatremia in 2007. There is a caveat to the use of conivaptan in hypervolemia: although vasopressin receptor antagonism Inhibitors,research,lifescience,medical could have potentially beneficial effects in congestive heart failure by decreasing afterload, attenuating coronary vasoconstriction, and potentially diminishing cardiac remodeling, STK38 current data do not support its use in this condition.11 On the contrary, the potential exists for increasing portal pressure, resulting in bleeding in the hyponatremia of cirrhosis related to increased splanchnic blood flow. Conivaptan leads to an increase in [Na+] by blocking V2 receptors, thus promoting water excretion while sparing electrolyte excretion.2 Although rapid correction of [Na+] with use of conivaptan has been documented,12 its use is still thought to be a more effective method to treat hyponatremia by virtue of its unique ability to increase solute-free water excretion by the kidneys.

Acknowledgments Dr. Clark is supported by a Career Development Award from the Department of Veterans Affairs (E6553W), entitled “Semantic Memory, Financial Capacity, and Brain Perfusion in MCI.” Data collection and sharing for this project were funded by the ADNI (National Cell Cycle inhibitor Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace

Inhibitors,research,lifescience,medical Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., F. Hoffman-La Roche, Schering-Plough, Synarc Inc., as well as nonprofit partners the Alzheimer’s Association and Alzheimer’s Drug Discovery Foundation, with participation from the US Food and Drug Administration. Inhibitors,research,lifescience,medical Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org).

The grantee organization is the Northern California Institute for Research and Education, Inhibitors,research,lifescience,medical and the study is coordinated by the Alzheimer’s Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. Dr. Inhibitors,research,lifescience,medical Glenn L. Clark provided useful comments on the manuscript.Current knowledge on fetal white matter (WM) maturation comes from post-mortem pathological studies (Gilles 1983; Brody et al. 1987). These studies have mainly focused on the myelination, the last step of WM maturation. Myelination is reported as a nonlinear complex phenomenon progressing with a spatio-temporal course specific to each species.

In humans, it begins at the second half of gestation and can evolve until the age of 20 for structures such as the Inhibitors,research,lifescience,medical corpus callosum (CC) (Kinney et al. 1988). Recent histological advances in immunostaining methods have allowed a better description of the cascade of cellular events characterizing the early phases (before myelination) of human fetal WM maturation on post-mortem samples (Back et al. 2002). These observations Terminal deoxynucleotidyl transferase confirm the existence of a premyelinating phase corresponding to the appearance of abundant “myelination glia,” composed by oligodendrocyte (OL) precursors and immature OL, as an essential step prior to the myelination process (Back et al. 2002). Although prenatal ultrasound and conventional T1- and T2-weighted MRI bring crucial information on the brain development of human fetuses in utero (Girard et al. 1995), the early cellular events involved in WM maturation are not yet accessible by these techniques.